Cargando…
Emerging Roles of SRSF3 as a Therapeutic Target for Cancer
Ser/Arg-rich (SR) proteins are RNA-binding proteins known as constitutive and alternative splicing (AS) regulators that regulate multiple aspects of the gene expression program. Ser/Arg-rich splicing factor 3 (SRSF3) is the smallest member of the SR protein family, and its level is controlled by mul...
Autores principales: | Zhou, Zhixia, Gong, Qi, Lin, Zhijuan, Wang, Yin, Li, Mengkun, Wang, Lu, Ding, Hongfei, Li, Peifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544984/ https://www.ncbi.nlm.nih.gov/pubmed/33072610 http://dx.doi.org/10.3389/fonc.2020.577636 |
Ejemplares similares
-
The biological function and clinical significance of SF3B1 mutations in cancer
por: Zhou, Zhixia, et al.
Publicado: (2020) -
Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma
por: Zhou, Zhixia, et al.
Publicado: (2022) -
SRSF3 Promotes Angiogenesis in Colorectal Cancer by Splicing SRF
por: Chen, Yinshuang, et al.
Publicado: (2022) -
Emerging roles of platelets in cancer biology and their potential as therapeutic targets
por: Wang, Lei, et al.
Publicado: (2022) -
SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)